164 related articles for article (PubMed ID: 17937466)
1. Immunization with DNA topoisomerase I induces autoimmune responses but not scleroderma-like pathologies in mice.
Hu PQ; Hurwitz AA; Oppenheim JJ
J Rheumatol; 2007 Nov; 34(11):2243-52. PubMed ID: 17937466
[TBL] [Abstract][Full Text] [Related]
2. Immunization with DNA topoisomerase I and Freund's complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling.
Yoshizaki A; Yanaba K; Ogawa A; Asano Y; Kadono T; Sato S
Arthritis Rheum; 2011 Nov; 63(11):3575-85. PubMed ID: 21792823
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis.
Kuwana M; Kaburaki J; Mimori T; Kawakami Y; Tojo T
Arthritis Rheum; 2000 May; 43(5):1074-84. PubMed ID: 10817562
[TBL] [Abstract][Full Text] [Related]
4. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis.
Kuwana M; Feghali CA; Medsger TA; Wright TM
Arthritis Rheum; 2001 Jul; 44(7):1654-9. PubMed ID: 11465716
[TBL] [Abstract][Full Text] [Related]
5. MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.
Rands AL; Whyte J; Cox B; Hall ND; McHugh NJ
J Autoimmun; 2000 Dec; 15(4):451-8. PubMed ID: 11090244
[TBL] [Abstract][Full Text] [Related]
6. Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis.
Hu PQ; Fertig N; Medsger TA; Wright TM
Arthritis Rheum; 2003 May; 48(5):1363-73. PubMed ID: 12746909
[TBL] [Abstract][Full Text] [Related]
7. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
[TBL] [Abstract][Full Text] [Related]
8. T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I.
Hu PQ; Oppenheim JJ; Medsger TA; Wright TM
J Autoimmun; 2006 Jun; 26(4):258-67. PubMed ID: 16735104
[TBL] [Abstract][Full Text] [Related]
9. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.
Kuwana M; Medsger TA; Wright TM
J Clin Invest; 1995 Jul; 96(1):586-96. PubMed ID: 7615831
[TBL] [Abstract][Full Text] [Related]
10. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
[TBL] [Abstract][Full Text] [Related]
11. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis.
Kuwana M; Medsger TA; Wright TM
J Immunol; 1995 Sep; 155(5):2703-14. PubMed ID: 7650398
[TBL] [Abstract][Full Text] [Related]
12. The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis.
Radić M; Martinović Kaliterna D; Ljutić D
Clin Exp Rheumatol; 2006; 24(4):407-12. PubMed ID: 16956431
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocyte antigen 4 (CD152) regulates self-reactive T cells in BALB/c but not in the autoimmune NOD mouse.
Piganelli JD; Poulin M; Martin T; Allison JP; Haskins K
J Autoimmun; 2000 Mar; 14(2):123-31. PubMed ID: 10677243
[TBL] [Abstract][Full Text] [Related]
14. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
15. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
Hénault J; Robitaille G; Senécal JL; Raymond Y
Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
[TBL] [Abstract][Full Text] [Related]
16. Heparin inhibits the interaction of DNA topoisomerase I/anti-topoisomerase I immune complexes with heparan sulfate on dermal fibroblasts.
Arcand J; Robitaille G; Koenig M; Senécal JL; Raymond Y
Arthritis Rheum; 2012 May; 64(5):1632-41. PubMed ID: 22095242
[TBL] [Abstract][Full Text] [Related]
17. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.
Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB
Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347
[TBL] [Abstract][Full Text] [Related]
18. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.
Gourh P; Tan FK; Assassi S; Ahn CW; McNearney TA; Fischbach M; Arnett FC; Mayes MD
Arthritis Rheum; 2006 Dec; 54(12):3945-53. PubMed ID: 17133608
[TBL] [Abstract][Full Text] [Related]
19. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
[TBL] [Abstract][Full Text] [Related]
20. Anti-topoisomerase I autoantibodies in systemic sclerosis.
Czömpöly T; Simon D; Czirják L; Németh P
Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
